593 related articles for article (PubMed ID: 17610345)
1. Endogenous and exogenous cardiac glycosides and their mechanisms of action.
Schoner W; Scheiner-Bobis G
Am J Cardiovasc Drugs; 2007; 7(3):173-89. PubMed ID: 17610345
[TBL] [Abstract][Full Text] [Related]
2. Endogenous cardiac glycosides: hormones using the sodium pump as signal transducer.
Schoner W; Scheiner-Bobis G
Semin Nephrol; 2005 Sep; 25(5):343-51. PubMed ID: 16139690
[TBL] [Abstract][Full Text] [Related]
3. Endogenous and exogenous cardiac glycosides: their roles in hypertension, salt metabolism, and cell growth.
Schoner W; Scheiner-Bobis G
Am J Physiol Cell Physiol; 2007 Aug; 293(2):C509-36. PubMed ID: 17494630
[TBL] [Abstract][Full Text] [Related]
4. Endogenous cardiotonic steroids.
Schoner W
Cell Mol Biol (Noisy-le-grand); 2001 Mar; 47(2):273-80. PubMed ID: 11355001
[TBL] [Abstract][Full Text] [Related]
5. Systemic hypertension: the roles of salt, vascular Na+/K+ ATPase and the endogenous glycosides, ouabain and marinobufagenin.
Hauck C; Frishman WH
Cardiol Rev; 2012; 20(3):130-8. PubMed ID: 22183064
[TBL] [Abstract][Full Text] [Related]
6. Endogenous cardiac glycosides, a new class of steroid hormones.
Schoner W
Eur J Biochem; 2002 May; 269(10):2440-8. PubMed ID: 12027881
[TBL] [Abstract][Full Text] [Related]
7. Endogenous cardiotonic steroids: physiology, pharmacology, and novel therapeutic targets.
Bagrov AY; Shapiro JI; Fedorova OV
Pharmacol Rev; 2009 Mar; 61(1):9-38. PubMed ID: 19325075
[TBL] [Abstract][Full Text] [Related]
8. Effects of two putative endogenous digitalis-like factors, marinobufagenin and ouabain, on the Na+, K+-pump in human mesenteric arteries.
Bagrov AY; Fedorova OV
J Hypertens; 1998 Dec; 16(12 Pt 2):1953-8. PubMed ID: 9886882
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory effect of combinations of digoxin and endogenous cardiotonic steroids on Na+/K+-ATPase activity in human kidney membrane preparation.
Touza NA; Pôças ES; Quintas LE; Cunha-Filho G; Santos ML; Noël F
Life Sci; 2011 Jan; 88(1-2):39-42. PubMed ID: 21047518
[TBL] [Abstract][Full Text] [Related]
10. The role of endogenous cardiotonic steroids in pathogenesis of cardiovascular and renal complications of arterial hypertension.
Paczula A; Więcek A; Piecha G
Postepy Hig Med Dosw (Online); 2016 Mar; 70():243-50. PubMed ID: 27117099
[TBL] [Abstract][Full Text] [Related]
11. [New steroid hormone family: endogenous cardiac glycosides and their role in physiologic and pathologic conditions].
Somogyi J; Szalay J; Pándics T; Rosta K; Csermely P; Vér A
Orv Hetil; 2004 Feb; 145(6):259-66. PubMed ID: 15038319
[TBL] [Abstract][Full Text] [Related]
12. Circulating bufodienolide and cardenolide sodium pump inhibitors in preeclampsia.
Lopatin DA; Ailamazian EK; Dmitrieva RI; Shpen VM; Fedorova OV; Doris PA; Bagrov AY
J Hypertens; 1999 Aug; 17(8):1179-87. PubMed ID: 10466474
[TBL] [Abstract][Full Text] [Related]
13. Effects of cardiac glycosides on sodium pump expression and function in LLC-PK1 and MDCK cells.
Liu J; Periyasamy SM; Gunning W; Fedorova OV; Bagrov AY; Malhotra D; Xie Z; Shapiro JI
Kidney Int; 2002 Dec; 62(6):2118-25. PubMed ID: 12427136
[TBL] [Abstract][Full Text] [Related]
14. Endogenous ouabain in renal Na(+) handling and related diseases.
Manunta P; Messaggio E; Casamassima N; Gatti G; Carpini SD; Zagato L; Hamlyn JM
Biochim Biophys Acta; 2010 Dec; 1802(12):1214-8. PubMed ID: 20226856
[TBL] [Abstract][Full Text] [Related]
15. Effects of two endogenous Na+,K(+)-ATPase inhibitors, marinobufagenin and ouabain, on isolated rat aorta.
Bagrov AY; Roukoyatkina NI; Pinaev AG; Dmitrieva RI; Fedorova OV
Eur J Pharmacol; 1995 Feb; 274(1-3):151-8. PubMed ID: 7768267
[TBL] [Abstract][Full Text] [Related]
16. Depth of the Steroid Core Location Determines the Mode of Na,K-ATPase Inhibition by Cardiotonic Steroids.
Tverskoi AM; Poluektov YM; Klimanova EA; Mitkevich VA; Makarov AA; Orlov SN; Petrushanko IY; Lopina OD
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948068
[TBL] [Abstract][Full Text] [Related]
17. The sodium pump and cardiotonic steroids-induced signal transduction protein kinases and calcium-signaling microdomain in regulation of transporter trafficking.
Liu J; Xie ZJ
Biochim Biophys Acta; 2010 Dec; 1802(12):1237-45. PubMed ID: 20144708
[TBL] [Abstract][Full Text] [Related]
18. Endogenous ligand of alpha(1) sodium pump, marinobufagenin, is a novel mediator of sodium chloride--dependent hypertension.
Fedorova OV; Talan MI; Agalakova NI; Lakatta EG; Bagrov AY
Circulation; 2002 Mar; 105(9):1122-7. PubMed ID: 11877366
[TBL] [Abstract][Full Text] [Related]
19. Marinobufagenin, an endogenous alpha-1 sodium pump ligand, in hypertensive Dahl salt-sensitive rats.
Fedorova OV; Kolodkin NI; Agalakova NI; Lakatta EG; Bagrov AY
Hypertension; 2001 Feb; 37(2 Pt 2):462-6. PubMed ID: 11230319
[TBL] [Abstract][Full Text] [Related]
20. The highly conserved cardiac glycoside binding site of Na,K-ATPase plays a role in blood pressure regulation.
Dostanic-Larson I; Van Huysse JW; Lorenz JN; Lingrel JB
Proc Natl Acad Sci U S A; 2005 Nov; 102(44):15845-50. PubMed ID: 16243970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]